Skip to content

IPSC - Century Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Century Therapeutics Inc

IPSC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IPSCCentury Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.04
52-wk low: $0.44
Prev close: $1.79
Mkt cap: $382.1M
Beta: 1.60
P/S: 3.7x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$71.4M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$13.5M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 54.5% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $382M

Valuation

P/S3.72
P/B1.52

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IPSC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $382.07M
Beta: 1.60

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-49.6%

$12.2M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$10.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IPSC

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.17-54.5%

-$0.11 expected

Next report

What the street expects next

EPS expected

-$0.12

-$0.14 to -$0.11

Revenue expected

$0.00

5 analysts

Estimate drift

+0.03

Change in 30 days

-49.6%

ROA-23.5%

Growth

Beta1.60